510 related articles for article (PubMed ID: 20173122)
1. StatBite: Key findings from the "Impact on clinical research of European legislation" report.
J Natl Cancer Inst; 2010 Mar; 102(5):293. PubMed ID: 20173122
[No Abstract] [Full Text] [Related]
2. European move affects academic trials research.
Sinha G
J Natl Cancer Inst; 2006 Aug; 98(16):1100-1. PubMed ID: 16912258
[No Abstract] [Full Text] [Related]
3. Germany opposes EU plans for regulating clinical trials owing to lack of ethical standards.
Tuffs A
BMJ; 2012 Oct; 345():e6640. PubMed ID: 23033377
[No Abstract] [Full Text] [Related]
4. [Ethics Review Boards discriminate the most severely ill--Swedish researchers are prevented to participate in an international study].
Björck M; Berg B; Hedin U; Wingren U
Lakartidningen; 2010 May 26-Jun 1; 107(21):1356-7. PubMed ID: 20645608
[No Abstract] [Full Text] [Related]
5. [Regulations of the ethical evaluation system of scientific and clinical research in connection with Poland joining the European Union].
Raszeja S
Arch Med Sadowej Kryminol; 2004; 54(2-3):151-4. PubMed ID: 15495560
[TBL] [Abstract][Full Text] [Related]
6. [Clinical trials contracts: quality assurance of the sub-contractor is the orderer's responsibility].
Karlmark B
Lakartidningen; 2008 Mar 18-Apr 1; 105(12-13):928; author reply 928. PubMed ID: 18461867
[No Abstract] [Full Text] [Related]
7. [How to face the ethical challenges of multicentric clinical investigation?].
Martínez SM
Medicina (B Aires); 2008; 68(4):345-6. PubMed ID: 18786895
[No Abstract] [Full Text] [Related]
8. One size does not fit all: toward "upstream ethics"?
Ozdemir V; Knoppers BM
Am J Bioeth; 2010 Jun; 10(6):42-4. PubMed ID: 20526970
[No Abstract] [Full Text] [Related]
9. Drug development: assessment of pharmacogenetic studies by Spanish research ethics committees.
Dal-Ré R; Luque I; Torres R; Lahuerta J
Pharmacogenomics J; 2009 Apr; 9(2):86-9. PubMed ID: 19079365
[TBL] [Abstract][Full Text] [Related]
10. EU ponders joint action on cancer.
Goodman S
Nature; 2002 Sep; 419(6903):101. PubMed ID: 12226626
[No Abstract] [Full Text] [Related]
11. European Union clinical trials directive.
Bull Med Ethics; 2001 Jul; (169):13-24. PubMed ID: 11878337
[No Abstract] [Full Text] [Related]
12. Viewpoint: are the research ethics committees working in the best interests of participants in an increasingly globalized research environment?
Chalmers D
J Intern Med; 2011 Apr; 269(4):392-5. PubMed ID: 21410787
[No Abstract] [Full Text] [Related]
13. Navigating the maze of requirements for obtaining approval of non-interventional studies (NIS) in the European Union.
Ramirez I
Ger Med Sci; 2015; 13():Doc21. PubMed ID: 26633964
[TBL] [Abstract][Full Text] [Related]
14. Can multiple IRBs spoil the broth?
Goldman EB
Ann Neurol; 2010 Feb; 67(2):149-50. PubMed ID: 20225267
[No Abstract] [Full Text] [Related]
15. Independent medical research.
van der Meer JW; de Gier AM; van Swaaij WP; Katan MB
Neth J Med; 2007 Apr; 65(4):124-6. PubMed ID: 17452759
[No Abstract] [Full Text] [Related]
16. [New European rules for clinical trials competition-promoting for Sweden...can we keep the advantage?].
Strandberg K
Lakartidningen; 2005 Mar 21-Apr 3; 102(12-13):962-5. PubMed ID: 15887643
[No Abstract] [Full Text] [Related]
17. Medical device development: from prototype to regulatory approval.
Kaplan AV; Baim DS; Smith JJ; Feigal DA; Simons M; Jefferys D; Fogarty TJ; Kuntz RE; Leon MB
Circulation; 2004 Jun; 109(25):3068-72. PubMed ID: 15226221
[No Abstract] [Full Text] [Related]
18. New EU regulation on clinical trials: the impact on ethics and safeguards for participants.
Boer AD; Schipper I
Indian J Med Ethics; 2013; 10(2):106-9. PubMed ID: 23697490
[TBL] [Abstract][Full Text] [Related]
19. Conflict of interest in biomedical research: a view from Europe.
Salvi M
Sci Eng Ethics; 2003 Jan; 9(1):101-8. PubMed ID: 12645233
[TBL] [Abstract][Full Text] [Related]
20. US clinical-research system in need of review.
Ammann AJ
Nature; 2013 Jun; 498(7452):7. PubMed ID: 23739388
[No Abstract] [Full Text] [Related]
[Next] [New Search]
